openPR Logo
Press release

Cancer Biomarkers Market: Envisaging Substantial Growth by 2030 | Abbott, Qiagen, Perkinelmer, Inc, Merck KgaA

01-15-2024 09:11 AM CET | Health & Medicine

Press release from: Congruence Market Insights

Cancer Biomarkers Market: Envisaging Substantial Growth by 2030

Cancer Biomarkers Market: Envisaging Substantial Growth by 2030

The latest report by Congruence Market Insights, titled 'Global Cancer Biomarkers Market - Size, Trends, Share, Growth, Dynamics, Competition, and Opportunity Forecast, 2023 - 2030,' provides a thorough analysis of the global cancer biomarkers market. The report meticulously examines both macro and micro trends, offering insights into the dynamic factors influencing the market. It encompasses a detailed exploration of qualitative and quantitative aspects, delivering a precise depiction of market size, growth rates, annual progression, prevailing trends, key drivers, promising opportunities, and potential challenges. Additionally, the report highlights the impact of crucial events such as new product launches or approvals, as well as the influence of external factors such as the COVID-19 pandemic and the Russia-Ukraine War on the cancer biomarkers market landscape. This exhaustive examination equips businesses and stakeholders with invaluable intelligence for making informed decisions in the evolving cancer biomarkers industry.

Request full report sample here: https://www.congruencemarketinsights.com/report/cancer-biomarkers-market?section=Request

What is the anticipated market size in 2030, along with the major drivers, restraints, and opportunities?

According to the in-depth market study, the global cancer biomarkers market is anticipated to reach a value of USD 44,711.6 Million by 2030 expanding at a CAGR of 15.3% between 2023 and 2030. The Global Cancer Biomarkers Market is propelled by increasing cancer incidence and advances in genomics. Opportunities arise from the integration of AI in diagnostics and the expanding field of immunotherapy. However, regulatory complexities and the need for extensive validation pose restraints. Market growth hinges on overcoming these challenges, harnessing technological innovations, and leveraging collaborations for effective biomarker development and implementation in personalized cancer care.

How does AI impact the Global Cancer Biomarkers Market?

In the global market for cancer biomarkers, artificial intelligence (AI) is crucial since it is transforming diagnosis and treatment. AI improves the analysis of large biomarker datasets, increasing the precision of cancer prognosis and detection. Through the prediction of treatment responses, machine learning algorithms facilitate the identification of intricate patterns, so contributing to personalized medicine. AI-driven insights also help identify new biomarkers, which promotes the development of innovative diagnostic instruments. AI integration speeds up the creation of more accurate, efficient, and customized cancer management strategies.

Buy Now @ https://www.congruencemarketinsights.com/buy-now/193/1

Scope of the Report:

► Executive Summary
► Demand and Supply-side Trends
► Market Drivers, Restraints, Opportunities and Challenges
► Value Chain Analysis
► Porter's Five Forces Analysis
► Industry SWOT Analysis
► COVID-19 Impact Assessment
► PESTLE Analysis
► Global Market Size and Forecast
► Regional Market Size and Forecast (Cross-country Analysis)
► Competition Landscape
► Company Profiles

Cancer Biomarkers Market Size and Forecast:

The report will comprehensively detail the cancer biomarkers market size and forecast (2023-2030), presenting key metrics for strategic insights. We will analyze market revenue, quantifying total income from cancer biomarkers sales, and provide volume insights into product circulation. The report will delineate market share, highlighting competitive landscapes. Year-on-Year growth analysis will track annual percentage changes, offering trend insights. Additionally, the Compound Annual Growth Rate (CAGR) will be presented, providing a smoothed growth rate for a more consistent assessment of the market's expansion over the forecast period.

Which region holds the largest market share, and where does the major opportunity lie in the future?

North America leads the world in cancer biomarkers market due to sophisticated research and a strong healthcare infrastructure, according to a regional analysis of the market. Europe is known for its strict regulatory framework and increasing emphasis on individualized treatment. Asia-Pacific is showing notable expansion, propelled by developing economies, R&D endeavors, and growing consciousness. Access to healthcare is a problem in Latin America, while demand for healthcare is rising throughout the Middle East and Africa due to rising cancer rates and the development of their healthcare infrastructure. International cooperation improves worldwide biomarker development and research initiatives.

Competition Landscape

The global cancer biomarkers market is highly competitive, with strong research efforts, strategic partnerships, and innovative product development. Leading participants concentrate on creating cutting-edge biomarker technologies, such as pharmaceutical companies and diagnostic businesses. Mergers and partnerships increase the resources available to find biomarkers. Prominent corporations such as Roche, Thermo Fisher Scientific, and Illumina continue to hold a dominant position in the market, but new entrants create a dynamic environment that supports technological innovation and a wide range of biomarker applications in cancer diagnosis and therapy. Below are some of the leading players operating in the market:

>> F. Hoffmann-La Roche Ltd.
>> Thermo Fisher Scientific Inc.
>> Abbott
>> QIAGEN
>> PerkinElmer, Inc.
>> Merck KGaA
>> Bio-Rad Laboratories, Inc.
>> Enzo Biochem, Inc.
>> Charles River Laboratories
>> Eurofins Scientific
>> Agilent Technologies, Inc.
>> Bruker
>> Siemens
>> Epigenomics AG
>> General Electric

Comprehensive Market Segmentation:

∆ By Type of Biomarker (Protein, Genetic, Glycan, and Metabolomic)
∆ By Technology (Imaging, Immunoassays, and Genomics/Proteomics)
∆ By Cancer Type (Breast, Prostate, Lung, Colorectal, Blood, and Other Specific Types)
∆ By Application (Diagnostics, Prognostics, Predictive, and Research)
∆ By End-User (Hospitals, Research Institutes, and Diagnostic Laboratories)

Market Segmentation by Geography including:

∆ North America: U.S., Canada and Mexico
∆ Europe: Germany, France, U.K., Italy, Spain, and Rest of Europe
∆ Asia Pacific: China, India, Japan, South Korea, Southeast Asia, and Rest of Asia Pacific
∆ South America: Brazil, Argentina, and Rest of Latin America
∆ Middle East & Africa: GCC Countries, South Africa, and Rest of Middle East & Africa

Frequently Asked Questions (FAQs):

► What is the current market scenario?
► What was the historical demand scenario, and forecast outlook from 2023 to 2030?
► What are the key market dynamics influencing growth in the global cancer biomarkers market?
► Who are the prominent players in the global cancer biomarkers market?
► What is the consumer perspective in the global cancer biomarkers market?
► What are the key demand-side and supply-side trends in the global cancer biomarkers market?
► What are the largest and the fastest growing geographies?
► Which segment dominated and which segment is expected to grow fastest?
► What was the COVID-19 impact on the global cancer biomarkers market?

Explore in-depth industry research reports across various verticals from Congruence Market Insights @ https://www.congruencemarketinsights.com/reports/all-industries

Related Reports:

https://www.congruencemarketinsights.com/report/virtual-oncology-market

https://www.congruencemarketinsights.com/report/radiation-dose-management-market

Contact Us:

Ms. Shalaka Dubey
Senior Sales Manager
Congruence Market Insights
Palo Alto, CA 94301, United States
Phone: +1 650-646-2623
Email: sales@congruencemarketinsights.com

About Us:

Congruence Market Insights is a leading market research firm dedicated to providing in-depth analysis and strategic solutions for businesses across diverse industries. With a focus on delivering actionable insights, we offer comprehensive market intelligence, trend analysis, and forecasting to empower informed decision-making. We have built a reputation for delivering practical insights and genuine reports across diverse sectors such as aerospace and defense, agriculture, building and construction, food and beverages, automotive, chemicals and materials, healthcare and pharmaceuticals covering an extensive array of both primary and niche sub-domains. Our expertise lies in uncovering market trends, consumer behavior, and competitive landscapes, enabling our clients to stay ahead in an ever-evolving business landscape.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market: Envisaging Substantial Growth by 2030 | Abbott, Qiagen, Perkinelmer, Inc, Merck KgaA here

News-ID: 3350429 • Views:

More Releases from Congruence Market Insights

Edge AI Software Market Brief Exploration to 2031: Growth Analysis, CAGR Status, Key Players and Future Scope
Edge AI Software Market Brief Exploration to 2031: Growth Analysis, CAGR Status, …
The recently published Edge AI Software Market Report 2024, spanning 169 pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly evolving business landscape, staying informed about the Edge AI Software Market is essential for businesses and marketers alike. This report is a valuable resource for gaining insights through in-depth research and analysis. It goes beyond mere data and statistics, serving as
Directed Energy Weapons Market New Update: Latest Trends, Dynamics, Upcoming Opportunities for the Forecast Period 2024 - 2031
Directed Energy Weapons Market New Update: Latest Trends, Dynamics, Upcoming Opp …
The recently published Directed Energy Weapons Market Report 2024, spanning 185 pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly evolving business landscape, staying informed about the Directed Energy Weapons Market is essential for businesses and marketers alike. This report is a valuable resource for gaining insights through in-depth research and analysis. It goes beyond mere data and statistics, serving as
Educational Toys Market Brief Exploration to 2031: Growth Analysis, CAGR Status, Key Players and Future Scope
Educational Toys Market Brief Exploration to 2031: Growth Analysis, CAGR Status, …
The recently published Educational Toys Market Report 2024, spanning 251 pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly evolving business landscape, staying informed about the Educational Toys Market is essential for businesses and marketers alike. This report is a valuable resource for gaining insights through in-depth research and analysis. It goes beyond mere data and statistics, serving as a strategic
Cement Board Market New Update: Latest Trends, Dynamics, Upcoming Opportunities for the Forecast Period 2024 - 2031
Cement Board Market New Update: Latest Trends, Dynamics, Upcoming Opportunities …
The recently published Cement Board Market Report 2024, spanning 235 pages, offers a comprehensive overview of the market's current state, size, volume, and market share. In today's rapidly evolving business landscape, staying informed about the Cement Board Market is essential for businesses and marketers alike. This report is a valuable resource for gaining insights through in-depth research and analysis. It goes beyond mere data and statistics, serving as a strategic

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For